نتایج جستجو برای: bare metal stents

تعداد نتایج: 219934  

Journal: :International heart journal 2017
Hiroyuki Jinnouchi Katsumi Inoue Yoshimitsu Soga Yusuke Tomoi Yohei Kobayashi Seiichi Hiramori Shinichi Shirai Kenji Ando

A 60-year-old man, who had claudication in his right limb due to total occlusion of the right superficial femoral artery, received bare metal stents. Although the bare metal stents in the superficial femoral artery did not show restenosis 5 years after stent implantation, angiography revealed significant in-stent restenosis when he developed right critical limb ischemia at 8 years post implanta...

2009
R Michael Kirchner J Dawn Abbott

Drug-eluting stents (DES) have had a major impact in interventional cardiology. Compared to bare metal stents, they significantly reduce restenosis and the need for target vessel revascularization. Four DES are available in the US, the first-generation sirolimus-eluting (Cypher((R))) and paclitaxel-eluting (Taxus((R))) stents and later approved second-generation everolimus-eluting (Xience V((R)...

Journal: :JACC. Cardiovascular interventions 2016
Piotr Sobieszczyk

SEE PAGE 828 T he superficial femoral artery (SFA), the longest artery in the human body, is subjected to nearly constant torsion, bending, and compression. It is perhaps natural to expect it to be the Achilles heel of endovascular interventions, plagued by higher rates of in-stent restenosis (ISR) compared to other arterial beds. Indeed, the 12-month rates of ISR after implantation of modern b...

Journal: :Zhonghua xin xue guan bing za zhi 2004
Allen Jeremias Brett Sylvia Jonathan Bridges Ajay J Kirtane Brian Bigelow Duane S Pinto Kalon K L Ho David J Cohen Lawrence A Garcia Donald E Cutlip Joseph P Carrozza

BACKGROUND Stent thrombosis (ST) is a rare but devastating complication of coronary stent implantation, occurring in 0.5% to 1.9% of patients with bare metal stents. The incidence of ST with drug-eluting stents is less well studied, particularly among patients outside of clinical trials. METHODS AND RESULTS The aim of this study was to evaluate the incidence and potential risk factors for ST ...

Journal: :The American journal of cardiology 2010
Lisette Okkels Jensen Michael Maeng Per Thayssen Anne Kaltoft Hans Henrik Tilsted Jens Flensted Lassen Knud Noerregaard Hansen Morten Bottcher Klaus Rasmussen Morten Madsen Søren Paaske Johnsen Henrik Toft Sørensen Leif Thuesen

Patients with diabetes mellitus have worse outcomes after percutaneous coronary intervention than patients without diabetes mellitus. We compared the risk of stent thrombosis, myocardial infarction, death, and target lesion revascularization in diabetic and nondiabetic patients after implantation of drug-eluting stents or bare metal stents. In the Western Denmark Heart Registry, 12,347 consecut...

Journal: :JAMA 2006
Gregg W Stone Stephen G Ellis Charles D O'Shaughnessy Steven L Martin Lowell Satler Thomas McGarry Mark A Turco Dean J Kereiakes Lynne Kelley Jeffrey J Popma Mary E Russell

CONTEXT Restenosis within bare-metal stents is often treated with repeat percutaneous coronary intervention, although subsequent recurrence rates are high, with vascular brachytherapy (VBT) affording the best results. The effectiveness of drug-eluting stents in this setting has not been established. OBJECTIVE To investigate the safety and efficacy of the polymer-based, slow-release paclitaxel...

Journal: :Circulation. Cardiovascular interventions 2016
Fernando Alfonso María José Pérez-Vizcayno Bruno García Del Blanco Arturo García-Touchard José-Ramón López-Mínguez Mónica Masotti Javier Zueco Rafael Melgares Vicente Mainar Raul Moreno Antonio Domínguez Juan Sanchís Armando Bethencourt José Moreu Angel Cequier Vicens Martí Imanol Otaegui Teresa Bastante Nieves Gonzalo Pilar Jiménez-Quevedo Alberto Cárdenas Cristina Fernández

BACKGROUND Treatment of patients with drug-eluting stent (DES) in-stent restenosis (ISR) is more challenging than that of patients with bare-metal stent ISR. However, the results of everolimus-eluting stents (EES) in these distinct scenarios remain unsettled. METHODS AND RESULTS A pooled analysis of the RIBS IV (Restenosis Intra-Stent of Drug-Eluting Stents: Paclitaxel-Eluting Balloon vs Ever...

Journal: :Biological & clinical sciences research journal 2023

Coronary artery disease is a condition that affects millions of people worldwide and can lead to serious complications such as heart attack or stroke. The study's main objective compare drug-eluting stents versus bare-metal for treating coronary disease. present study aimed the efficacy safety (DES) bare metal (BMS) treatment (CAD). was conducted at two tertiary care hospitals, Hayatabad Medica...

Journal: :Health technology assessment 2004
R Hill A Bagust A Bakhai R Dickson Y Dündar A Haycox R Mujica Mota A Reaney D Roberts P Williamson T Walley

OBJECTIVES To assess the effectiveness and cost-effectiveness of the use of coronary artery stents in patients with coronary heart disease (CHD). DATA SOURCES Electronic databases. REVIEW METHODS The review was conducted following accepted guidelines for conducting systematic reviews. Randomised controlled trials that include comparisons of percutaneous transluminal coronary angioplasty (PT...

Journal: :JAMA surgery 2014
Laura A Graham Brandon A Singletary Joshua S Richman Thomas M Maddox Kamal M F Itani Mary T Hawn

IMPORTANCE In 2007, the American College of Cardiology/American Heart Association guidelines were revised for patients with cardiac stents in need of subsequent surgery to recommend delaying elective noncardiac surgery by 365 days in patients with drug-eluting stents (DESs). OBJECTIVE To examine the effect of the guidelines on postoperative major adverse cardiac events (MACEs) in subsequent n...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید